Results 201 to 210 of about 10,952 (242)
Some of the next articles are maybe not open access.
Compassionate use of psychedelics
Medicine, Health Care and Philosophy, 2020In the present paper, we discuss the ethics of compassionate psychedelic psychotherapy and argue that it can be morally permissible. When talking about psychedelics, we mean specifically two substances: psilocybin and MDMA. When administered under supportive conditions and in conjunction with psychotherapy, therapies assisted by these substances show ...
Adam Greif, Martin Šurkala
openaire +2 more sources
The history of psychedelics and why psychedelic stories matter
Open Access Government, 2023The history of psychedelics and why psychedelic stories matter Erika Dyck argues that how people learn about psychedelics today matters, based on the histories of these drugs and how they have been and should be used in clinical medicine.
openaire +1 more source
Psychedelic Drugs in Biomedicine
Trends in Pharmacological Sciences, 2017Psychedelic drugs, such as lysergic acid diethylamide (LSD), mescaline, and psilocybin, exert profound effects on brain and behavior. After decades of difficulties in studying these compounds, psychedelics are again being tested as potential treatments for intractable biomedical disorders.
Evan J, Kyzar +4 more
openaire +2 more sources
Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy
Journal of Psychoactive DrugsThis study evaluated the attitudes, knowledge, and educational experiences of psychiatry residents regarding psychedelics and psychedelic-assisted therapy (PAT). In 2023, we distributed an anonymous survey to United States psychiatry residents, assessing demographics, knowledge, and opinions on psychedelics/PAT.
Brian S. Barnett +6 more
openaire +2 more sources
Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry
Journal of Psychoactive Drugs, 2014Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on a group of compounds that could have great potential. Without the validation of the medical profession, the psychedelic drugs, and those who take them off-license, remain archaic sentiments of the past, with the users maligned as recreational drug abusers and ...
openaire +2 more sources
Psychedelic research at a crossroads
ScienceThere is an urgent need to develop better treatments for mental health conditions that affect one in every eight people in the world. To combat this concern, psychedelic drugs have been combined with psychotherapy and studied in clinical trials in the United States and Europe.
Stacey B, Armstrong, Alan K, Davis
openaire +2 more sources
The science of psychedelic medicine
Nature MedicineClassic psychedelics typically act at the serotonin 5-HT2A receptor to profoundly alter brain function and consciousness. Research on these compounds has accelerated. Major strides have been made in understanding their unique mechanisms of action and clinical potential. This Review outlines the state of psychedelic science, spanning cellular mechanisms,
Joshua S. Siegel +4 more
openaire +2 more sources
Psychedelics in Psychiatry, the Nursing Influence, and the Future of Psychedelic Therapies
Journal of the American Psychiatric Nurses AssociationOBJECTIVE: Psychedelics and psychedelic-assisted therapies (PATs) are on the cusp of becoming medicalized treatment modalities within the United States, both as potential U.S. Food and Drug Administration (FDA)-approved treatment and therapeutic options outside the medical model, through decriminalization ...
openaire +2 more sources
Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Neuroscience and Biobehavioral Reviews, 2022Michiel van Elk
exaly